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Natural products provide rich inspiration in the discovery of bioactive small molecules, and have 
played a dominant role in shaping early-stage drug discovery.1  Indeed, of the 1211 small-molecule 
drugs that were approved between 1981 and 2014, 6% were unaltered natural products and 26% were 
natural product derivatives.1  Yet, the structural complexity of natural products means that the 
development of viable total syntheses is usually time-consuming and resource-intensive.  In most 
cases, total syntheses are bespoke, although divergent syntheses have also been developed to access 
natural products based on the same, or several closely-related, scaffolds.2  In contrast, families of 
biosynthetic enzymes, such a terpenoid cyclases,3 can enable common intermediates to be converted 
into many diverse molecular scaffolds.  How, then, can synthetic chemists best harness4 the chiral pool 
to drive both the discovery, and the subsequent supply, of natural product-inspired drugs?  This 
challenge is likely to require chemists to harness a wide reaction toolkit5 that integrates both bio- and 
chemocatalysis.6  On page XX, Li et al report that a toolkit of radical-based chemistries could be 
harnessed to yield nine distinct meroterpenoid natural products.7 
Retrosynthetic analysis revealed that two key intermediates (3 and 7) might be exploited in the 
synthesis of all nine natural product targets (Figure 1).  It was recognised that these intermediates 
might be prepared from two readily-available starting materials, sclareolide 1 and sclareol 4, provided 
that chemoselective oxidation was possible.  However, it was noted that oxidations of sclareolide are 
generally selective for the C2 position rather than for the required C3 position.  To address this 
challenge, a range of P450BM3 variants was screened, leading to the identification of a variant, BM3 
MERO1, that enabled chemoselective oxidation of sclareolide 1 to yield 2 in 60-70% yield.  This 
biotransformation was possible on a gram scale, contrasting with previous examples that had been 
performed at high dilution on, at most, a 50 mg scale.  It is interesting to contrast this early-stage 
oxidation, which needed to be performed on a relatively large scale, with a total synthesis of 
Nigelladine A in which a late-stage oxidation was catalysed by an engineered P450 enzyme.8  The 
hydroxylated product 2 was converted into the key intermediate 3 in four further steps. 
The synthesis of the key intermediate 7 was achieved in seven steps from sclareol 4.  Here, a key 
step was a hydrogen atom transfer (HAT) based Giese coupling which enabled introduction of the third 
fused ring with excellent diastereoselectivity.  Crucially, this coupling proceeded in excellent yield on 
a gram scale, enabling it to be harnessed at an early stage in the divergent synthesis.  Alanine scanning 
on BM3 MERO1 enabled the identification of a point mutant (L75A) that was superior for the 
chemoselective oxidation step: with this mutant, hydroxylation was possible in 62% yield on a gram 
scale (compared to 33% for MERO1), and with excellent chemo- and diastereoselectivity. 
A reaction toolkit was then developed to append the additional rings found in the natural product 
targets, and to control the oxidation level of specific carbon atoms.  For example, dehydration of the 
E-hydroxy aldehyde 3 could be followed by condensation with an appropriate 4-hydroxy pyrone to 
yield the fused ring system found in the D-pyrone meroterpenoids 8-12.  In the case of 9, 10 and 12, 
a HAT-based reduction enabled hydrogenation of an intermediate alkene with high 
diastereoselectivity; in contrast, hydrogenation under many other conditions resulted in over-
reduction of the pyrone motif.  
Radical-based chemistry was also used to fuse additional rings to the key intermediate 7.  Nickel-
catalysed cross-couplings involving the alkyl iodide 7 enabled introduction of appropriate (het)aryl 
rings; subsequent acid-catalysed cyclisation onto the alkene yielded the fused ring systems found in 
chevalone A 13 and taondiol 14.  The possibility of reducing the number of synthetic steps may serve 
as a spur for the development of new methods that would enable earlier intermediates to be exploited 
in place of the iodide 7.  Nonetheless, exploitation of the iodide 7 allowed elimination to give a useful 
1,3-diene intermediate; efficient electrochemical coupling with a phenol or a 4-hydroxy pyrone then 
yielded the spiro-fused ring systems found in stypodiol 15 and decaturin E 16. It is notable that the 
exploitation of a toolkit of radical reactions enabled the use of protecting groups to be largely avoided.  
Whilst focus was placed on the synthesis of natural products, exploitation of these methods to prepare 
additional related scaffolds could have demonstrated their wider value.   
This work demonstrates that it is possible to harness abundant chiral feedstocks effectively 
provided that an expanded underpinning reaction toolkit is in place.  Here, bio- and chemo-catalytic 
radical-based chemistries were used in combination to prepare nine meroterpenoids from two 
readily-available starting materials.  This study complements the use of halogenases to functionalise 
diverse substrates.9  Wider adoption of an integrated toolkit of bio- and chemo-catalysed methods 
may broaden the natural product-inspired chemical space that is available for discovery.  Such 
methods may enable the derivatisation of natural products in new ways,1 the synthesis of new natural 
product-inspired scaffolds,10 and the fusion of natural product sub-structures to yield pseudo-natural 
products with novel functions!11 
 Figure legend:  Divergent synthesis of nine meroterpenoid natural products.  The synthesis of two 
key intermediates (top) enabled the synthesis of the natural product targets (bottom). 
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